ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 3442 for:    Louisville
Previous Study | Return to List | Next Study

Increasing PrEP Among African Americans in Louisville KY

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03559595
Recruitment Status : Recruiting
First Posted : June 18, 2018
Last Update Posted : June 18, 2018
Sponsor:
Information provided by (Responsible Party):
Jelani Kerr, University of Louisville

Brief Summary:
This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Condition or disease Intervention/treatment Phase
HIV/AIDS PREVENTION Behavioral: Project Prevent Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY
Actual Study Start Date : June 4, 2018
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention group
All study participants will be exposed to the intervention
Behavioral: Project Prevent
The Project Prevent intervention entails 1) a media campaign to raise PrEP awareness, 2) geographically targeted education initiatives with medical personnel to increase access to consumers, and 3) programming with AIDS service organizations to improve service delivery around PrEP.




Primary Outcome Measures :
  1. PrEP uptake [ Time Frame: 12 months ]
    Reported use of PrEP


Secondary Outcome Measures :
  1. PrEP intentions [ Time Frame: 12 months ]
    Intention to use PrEP

  2. PrEP prescription [ Time Frame: 12 months ]
    Prescription of PrEP to eligible individuals by medical personnel



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 29 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Between ages 18-29 years old
  • Self-identifies as African American or Black
  • Resident of Louisville, KY
  • Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships).
  • Not diagnosed with HIV

Exclusion Criteria:

  • Older than 29 and younger than 18 years old
  • Does not identify as African American or Black
  • Does not reside in Louisville, KY
  • Not a member of a priority group
  • Diagnosed with HIV

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03559595


Contacts
Contact: Toya Northington 502-852-1908 Toya.northington@louisville.edu

Locations
United States, Kentucky
University of Louisville Recruiting
Louisville, Kentucky, United States, 40202
Contact: Toya Northington       toya.northington@louisville.edu   
Sponsors and Collaborators
University of Louisville

Responsible Party: Jelani Kerr, Assistant Professor, University of Louisville
ClinicalTrials.gov Identifier: NCT03559595     History of Changes
Other Study ID Numbers: ULouisville
First Posted: June 18, 2018    Key Record Dates
Last Update Posted: June 18, 2018
Last Verified: June 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No